Compound having TAFIa inhibitory activity

Details for Australian Patent Application No. 2009310841 (hide)

Owner Taisho Pharmaceutical Co., Ltd.

Inventors Amada, Hideaki; Matsuda, Daisuke; Bohno, Masahiro; Saito, Shiuji; Bohno, Ayako

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2009310841

PCT Pub. Number WO2010/050525

Priority 2008-278302 29.10.08 JP

Filing date 28 October 2009

Wipo publication date 6 May 2010

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/4745 (2006.01)

A61K 31/5383 (2006.01)

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

A61P 27/02 (2006.01) Drugs for disorders of the senses

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 471/14 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

C07D 498/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

2 June 2011 Amendment Made

  The nature of the amendment is: Amend the invention title to read Compounds having TAFIa inhibitory activity

2 June 2011 PCT application entered the National Phase

  PCT publication WO2010/050525 Priority application(s): WO2010/050525

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009310907-Mobile telecommunication station and mobile telecommunication method

2009310835-High strength stainless steel piping having outstanding resistance to sulphide stress cracking and resistance to high temperature carbon dioxide corrosion